This week we look at the far-reaching impact of the human BRAIN initiative, ways pharma can embrace healthcare Big Data, the slow progress on developing superbug drugs, the news that Big Pharma is now being outpaced by Big Biotech and the importance of the ePatient of 2015:
– The perspective in Why The Human BRAIN Initiative Is So Important To All Of Us from Business2Community explains how the initiative will impact far more than just biology, neuroscience and nanoscience. It’s also going to affect all areas of science and technology… including medical informatics, new computer modeling and advanced simulations to name a few
– Making good use of Big Data is not just about technology, but also having a clear business case and internal support. How Pharma Can Embrace Healthcare Big Data from pharmaphorum outlines opportunities and challenges for identifying and implementing Big Data solutions within pharma
– The Huffington Post’s Healthy Living’s Superbug Drugs: Only 7 New Drugs In Development For Antibiotic-Resistant Bacteria shares data from the latest report by the Infectious Diseases Society of America (IDSA). They have been tracking the rising number of bacteria that resist even the most potent antibiotics and reveal that only seven new drugs are in development for the treatment of infections caused by superbugs – that include E. coli and CRE
– Big Biotech experienced a 57% increase in market cap for the three years ending December 31, 2012, compared to a 17.4% increase for Big Pharma during the same period. PharmaTimes’ Big Biotech Growth “Outpacing Big Pharma” covers findings from a recent analysis by financial services firm Burrill & Co
– MediaPost’s Marketing:Health provides reasons Why You Should Care About The Health-Aware, Connected And Cost-Conscious ePatient Of 2015 as digital technologies will play an increasingly important role in how people learn about and manage their care
That wraps this week’s review of news from and for the pharma market research community. I’ll leave you with an invitation to learn more about the benefits of real time data and offer you a personal demo of InCrowd’s on-demand platform providing you direct and immediate access to Crowds of screened and targeted healthcare professionals.
If you have tips, suggestions, or resources you’d like to share leave us a comment below and please feel free to suggest topics that you’d like to see covered in future posts.
